CoChat

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 19 of the 89 sources its claims cite were checked for support.

Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: A randomised controlled trial

Open access
Alda, Marta, Luciano, Juan V, Andrés, Eva, Serrano-Blanco, Antoni, Rodero, Baltasar, del Hoyo, Yolanda López, Roca, Miquel, Moreno, Sergio, Magallón, Rosa, García-Campayo, Javier · 2011 · Arthritis Research & Therapy

Abstract

Introduction: No randomised, controlled trials have been conducted to date on the efficacy of psychological and pharmacological treatments of pain catastrophising (PC) in patients with fibromyalgia. Our aim in this study was to assess the effectiveness of cognitive-behaviour therapy (CBT) and the recommended pharmacological treatment (RPT) compared with treatment as usual (TAU) at the primary care level for the treatment of PC in fibromyalgia patients. Methods: We conducted a six-month, multicenter, randomized, blinded, parallel group, controlled trial in which patients were randomly assigned to one of three study arms: CBT (n = 57), RPT (n = 56) and TAU at the primary care level (n = 56). The major outcome of this study was PC in patients with fibromyalgia. The secondary variables were pain acceptance, depression, anxiety, pain, global function and quality of life. Results: CBT significantly decreased global PC at the six-month follow-up examination with effect sizes of Cohen's d = 0.73 and 1.01 compared with RPT and TAU, respectively. CBT was also more effective than RPT and TAU at increasing pain acceptance at the six-month follow-up examination (effect sizes of Cohen's d = 0.77 and 0.80, respectively). Compared with RPT and TAU, CBT was more effective at improving global function based on the Fibromyalgia Impact Questionnaire (six-month effect sizes Cohen's d = 0.44 and 0.53, respectively) and quality of life based on the European Quality of Life Scale (six-month effect sizes Cohen's d = 0.11 and 0.40, respectively). There were no differences among the three treatments with regard to pain and depression. Conclusions: CBT shows higher efficacy than RPT and TAU not only in key outcomes in FM, such as function and quality of life, but also in relevant mediators of treatment effects, such as pain catastrophising and pain acceptance. © 2011 Alda et al.

Overview

CoChat Summary

## TL;DR

In this 6-month randomized controlled trial in primary care fibromyalgia patients, cognitive-behaviour therapy (CBT) outperformed recommended pharmacological treatment (RPT) and treatment as usual (TAU) for reducing pain catastrophizing and improving several broader outcomes. The trial found no between-group differences for pain or depression overall, but CBT improved pain acceptance, global function, and quality of life.

## Key findings

  • CBT significantly decreased global pain catastrophizing at 6 months, with effect sizes of Cohen’s d = 0.73 versus RPT and 1.01 versus TAU.
  • CBT was also more effective than RPT and TAU for pain acceptance at 6 months (Cohen’s d = 0.77 and 0.80), global function on the Fibromyalgia Impact Questionnaire (d = 0.44 and 0.53), and quality of life on the EuroQol VAS (d = 0.11 and 0.40).
  • There were no differences among the three treatments for pain and depression overall; in the discussion, the authors note CBT and RPT improved anxiety more than TAU.
  • RPT was more effective than TAU for reducing all three PCS dimensions; the paper also reports that CBT was more effective than the other two treatments for rumination, magnification, and helplessness at posttreatment and follow-up.

## Methods

  • Six-month, multicentre, randomized, blinded, parallel-group controlled trial with 1:1:1 assignment to CBT (n = 57), RPT (n = 56), or TAU (n = 56); evaluators and assessment staff were blinded, but patients and therapists were not.
  • Patients were recruited from 41 primary healthcare centres in Zaragoza, Spain; 169 enrolled, 168 received allocated intervention, and 141 completed the study (83.9%).
  • Main analysis used intention-to-treat participants with at least baseline and one posttreatment measurement, last observation carried forward, and ANCOVA adjusting for baseline scores; pairwise contrasts were Bonferroni-adjusted.

## Limitations

  • The authors explicitly state that one main limitation was the number of secondary variables analyzed, which raises concern about type I error.
  • They state that new randomized controlled trials with larger samples are needed to determine CBT’s role in standard care; this indicates the present sample was not large enough for definitive conclusions.
  • Evident from the text: patients and therapists were not blinded to treatment assignment, which could have introduced performance bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/ar3496

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flowchart of the study.
Figure 1 Flowchart of the study.CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 5 Not valid · 39 Not checked · 65 Own results and interpretations

47 more claims

Create a free account to see all 122 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 56
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Research works printed but not linked: 3

  1. García-Campayo J, López A: Aprender a Vivir con la Fibromialgia [To Learn to Live with Fibromyalgia] [in Spanish]. 2006, Barcelona: Edikamed
  2. Marzo Arana J, Martinez O, Gaspar Escayola JI, Orozco F, García Campayo J, Martin J, Marzo Gracia J: Protocolo para el Abordaje de la Fibromialgia en el Sistema de Salud de Aragón [Protocol for the Treatment of Fibromyalgia at the Aragon Health System] [in Spanish]. 2006, Zaragoza: Gobierno de Aragón
  3. Ferrando L, Soto M, Bobes J, Soto O, Franco L, Gubert J: M.I.N.I. Mini International Neuropsychiatric Interview. Versión en Español 5.0.0. 1998, DSM-IV. Madrid: Instituto IAP

Cited by

See all 77

Metadata

Authors
Alda, M., Luciano, J. V., Andrés, E., Serrano-Blanco, A., Rodero, B., del Hoyo, Y. L., Roca, M., Moreno, S., Magallón, R., & García-Campayo, J.
Affiliations
  • Universidad de Zaragoza (ES)
  • Red de Investigación en Actividades Preventivas y Promoción de la Salud (ES)
Venue
Arthritis Research & Therapy
Published
2011-10-23
Volume
13
Issue
5
Pages
R173-R173
ISSN
1478-6354 (ISSN-L)
OpenAlex
W2132889637
Cited by
77
References
60
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 3 · 2013: 8 · 2012: 6
FWCI
4.16
Type
journal article
Language
en
Open access
Licence
Locations
  • Arthritis Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
cognitive behavioral therapy, pain catastrophizing, fibromyalgia, pain acceptance, pharmacotherapy, primary care, quality of life, global function, depression, anxiety
MeSH terms
Pregabalin, Adult, Female, Fibromyalgia, Follow-Up Studies, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Pain Measurement, Cognitive Behavioral Therapy, Single-Blind Method, Treatment Outcome, Catastrophization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.